It is possible that accumulated free ISG15 stabilizes USP18 in cancer cells expressing low levels of UBE1L and high levels USP18, which in turn removes the ISG15 degradation signal from the target proteins (e.g., Cyclin D1), consequently stabilizing these protumor proteins. The gene discussed is USP18; the disease is cancer.